Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 12, 2011 Todd Wenning	What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors.
The Motley Fool February 8, 2006 Tim Beyers	Best Blue Chip: GE In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: GE's management commitment, growth, and dividend yield are too enticing and offer a more powerful combination than any of the others in this sterling field.
The Motley Fool August 3, 2005 Steven Mallas	JNJ: One to Monitor Johnson & Johnson might not exactly be a bargain, but it should always be on your stock watch list.
The Motley Fool February 8, 2006 W.D. Crotty	Best Blue Chip: ExxonMobil In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: ExxonMobil is the best of this bunch -- and its products fuel the industrialized world.
The Motley Fool November 9, 2006 Shruti Basavaraj	The Best Blue Chip for 2007: Johnson & Johnson If you're out looking for the best blue chip money can buy, consider Johnson & Johnson. The stock combines strong growth opportunities with stability. It's the ideal stock to build the core of your portfolio.
The Motley Fool February 8, 2006 Rick Aristotle Munarriz	Best Blue Chip: Coca-Cola In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: Coca-Cola is bold, cold, and oh so worthy of that gold.
The Motley Fool August 28, 2010 Todd Wenning	Dividend Report Card: Johnson & Johnson Does this health-care titan's dividend pass the test?
The Motley Fool January 18, 2012	What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance.
The Motley Fool February 10, 2006 Rick Aristotle Munarriz	Best Blue Chip: Altria Strikes Gold The first gold medal in the stock competition is awarded for the Best Blue Chip: Altria. The company formerly known as Philip Morris has delivered an annualized return of 19.75% since 1957.
The Motley Fool September 24, 2010 Anand Chokkavelu	10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list
The Motley Fool October 7, 2010 Anand Chokkavelu	How Johnson & Johnson Really Makes Money Hint: It's not Tylenol.
The Motley Fool May 1, 2006 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Let's take a closer look at four of the companies that inched their payouts higher this past week: Valero Energy... Charles Schwab... IBM... Johnson & Johnson... etc.
The Motley Fool April 19, 2005 Nathan Slaughter	Diagnosis: JNJ A-OK The health-care conglomerate beats expectations on strong international results.
The Motley Fool April 13, 2004 Alyce Lomax	J&J Makes the Day It may be over a hundred years old, but the company reports a spry first quarter.
The Motley Fool February 16, 2006 Tim Beyers	Best Small Cap: Quality Systems In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: Quality Systems has all the ingredients to also make it to the top of the podium.
The Motley Fool May 26, 2010 Brian Orelli	Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues.
The Motley Fool July 14, 2008 Brian Orelli	Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut?
The Motley Fool October 19, 2011 Brian Orelli	Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson.
The Motley Fool December 23, 2005 Nathan Parmelee	The Investing Strategy That Keeps Giving The best results from dividends require patience, a long-term time horizon, and excellent companies for your investment dollars.
The Motley Fool October 12, 2004 Alyce Lomax	Take It Away, J&J Should investors sweat a coming slowdown in growth for pharmaceutical and consumer products giant Johnson & Johnson?
The Motley Fool February 21, 2006 David Meier	Biggest Disappointment: Blockbuster In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: Big disappointments are a value investor's meat and potatoes. Could the Bode Miller of video rentals win gold in Vancouver?
The Motley Fool June 20, 2006 Shruti Basavaraj	Doubles Are Better Than Home Runs Loads of investors think they want to find the next home run stock. These potential 10-baggers keep many of us in the investing game. While it's good to aim for the fences, investors should be content with the doubles.
The Motley Fool July 31, 2007 Nathan Parmelee	Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business.
The Motley Fool October 17, 2006 Brian Lawler	See Johnson & Johnson Crawl Earnings growth isn't moving right along because the company has become so big. Investors, take note.
The Motley Fool November 26, 2010 Brian Orelli	Get It Together, Johnson & Johnson Another day, another recall.
The Motley Fool December 18, 2008 Selena Maranjian	Best Stock for 2009: Johnson & Johnson Johnson & Johnson is a stock that should let you sleep well at night in 2009.
The Motley Fool February 22, 2006 Rick Aristotle Munarriz	Best International Company: Lloyds TSB In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: It's hard to argue against a company that has been at it since 1765 -- Britain's Lloyds TSB.
The Motley Fool December 29, 2011 Matt Thalman	3 Companies That Give Back to Shareholders These three companies have consistently increased the value of each outstanding share: UPS... Johnson & Johnson... ExxonMobil...
The Motley Fool September 2, 2008 Todd Wenning	Supercharge Your Income With These Stocks Dividend stocks offer the best option, but you need to start now.
The Motley Fool April 16, 2010 Chuck Saletta	Don't Time the Market. Do This. Profiting by investing in good companies takes significantly longer than hoping to capture a quick run for massive profits, but it's also something you can figure out -- and trust over the long term.
Sports Illustrated April 11, 2001 E.M. Swift	Setting the record straight Skier Bill Johnson reigned at more than just Sarajevo...
The Motley Fool July 20, 2010 Brian Orelli	Is J&J a Bad News Buy? Another quarter in 2010, another lowered earnings guidance for Johnson & Johnson. At least the year is half over for the health-care giant.
The Motley Fool February 28, 2011 Brian Orelli	Johnson & Johnson Parties Like It's 1982 The big pharma announced that it was recalling 667,632 packages of Sudafed tablets because the instructions contained a typo.
The Motley Fool July 9, 2010 Brian Orelli	Hey, Johnson & Johnson: Eight Is Enough If Johnson & Johnson can't overcome the negative image from recalls quickly, consumers will head to competing brand-name drugs or just grab generic versions of Johnson & Johnson's products.
The Motley Fool January 3, 2011 Rex Moore	Highest-Yielding Pharma Stocks (You Might Actually Want to Buy) How to combine high yield with low risk.
The Motley Fool June 25, 2010 Brian Orelli	The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error.
The Motley Fool June 21, 2010	The One Thing Beginning Dividend Investors Overlook Asked for the biggest mistake beginning dividend investors make, Motley Fool advisor James Early pointed to ignoring the quality of the dividend.
The Motley Fool August 11, 2010 David Meier	Does Bill Miller Think Johnson & Johnson Is Attractive? Johnson & Johnson fits Miller's criteria perfectly. It pays a 3.6% dividend that has been growing 11.1%, on average, for the past five years.
The Motley Fool February 3, 2006 Andy Cross	Three Blue Chips Go for the Gold Gold Medal: Anheuser-Busch... Silver Medal: Johnson & Johnson... Bronze Medal: Bank of America...
The Motley Fool March 25, 2010 Anand Chokkavelu	Your Next Big Dividend Stock These are some really good candidates: Merck... ConAgra Foods... Johnson & Johnson... Marathon Oil... Sysco... FPL Group... McDonald's...
The Motley Fool August 25, 2010 Selena Maranjian	How to Beat Your Bank There are so many ways to beat the return of a bank savings account these days, you'd be crazy to not take advantage of them.
The Motley Fool August 27, 2010 Brian Orelli	A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much.
The Motley Fool September 17, 2010 James Early	Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care.
The Motley Fool January 20, 2009 Brian Orelli	Johnson & Johnson Nimble ... for Now The health-care giant reports increasing earnings, despite falling revenue.
The Motley Fool October 27, 2009 Adam J. Wiederman	The Easiest Way to Become a Millionaire This strategy is simple, but it takes discipline to adhere to the rules. But if you follow this advice, you'll be well on your way to a million-dollar portfolio.
The Motley Fool March 8, 2010 Jim Royal	5 Stocks for the Good Life The lowest-risk, most secure way to a great retirement may be to invest in blue-chip stocks.
The Motley Fool August 29, 2008 Richards et al.	Fool Blog: Stocks We'd Recommend to Our Grandmas In lieu of this crazy market, analysts suggest stocks they would recommend for their own grandmothers?
The Motley Fool October 13, 2008 Brian Orelli	Foolish Forecast: J&J's Diversity Counts Views you can use to get clues on tomorrow's news
The Motley Fool December 1, 2008 Brian Orelli	Johnson & Johnson Firms Things Up The health-care giant acquires breast-implant maker Mentor.
The Motley Fool August 14, 2007 Brian Orelli	A No-Win Situation Johnson & Johnson is suing the beloved American Red Cross for trademark infringement. Johnson & Johnson just needs to walk a fine line between having its brand eroded by the Red Cross and having its brand eroded by a public relations nightmare.